Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international b.v. - leptospira interrogans serogroup australis (inactivated) 2380 u/dose; porcine parvovirus (inactivated) 300 u/dose; leptospira santarosai serogroup tarassovi (inactivated) 500 u/dose; leptospira kirschneri serovar gryppotyphosa (inactivated) 1086 u/dose; leptospira interrogans serovar icterohaemorrhagiae (inactivated) 520 u/dose; leptospira interrogans serovar canicola (inactivated) 6250 u/dose; erysipelothrix rhusiopathiae (inactivated) 300 mg/dose; leptospira interrogans serogroup pomona (inactivated) 500 - suspension for injection - erysipelothrix rhusiopathiae; leptospira interrogans canicola; leptospira interrogans icterohaemorrhagiae; leptospira interrogans australis; porcine parvovirus; leptospira kirschneri grippotyphosa; leptospira interrogans pomona; leptospira santarosai tarassovi - porcine parvovirus + erysipelothrix + leptospira - pig

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - erysipelothrix rhusiopathiae; leptospira interrogans serovar pomona; porcine parvo virus; formaldehyde; thiomersal - parenteral liquid/solution/suspension - erysipelothrix rhusiopathiae vaccine-general active 0.0 u; leptospira interrogans serovar pomona vaccine-microbial active 0.0 u; porcine parvo virus vaccine-viral active 0.0 u; formaldehyde aldehyde other 0.3 mg/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - erysipelas - swine | leptospirosis - leptospira pomona | parvovirus | vaccine | equine rotavirus | l. interrogans serovar pomona | leptospira pomona infection | swine erysipelas

European Union - English - EMA (European Medicines Agency)

zoetis belgium s.a. - leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091 (all inactivated) - inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia), immunologicals for canidae - dogs - active immunisation of dogs from six weeks of age to prevent clinical signs, infection and urinary excretion caused by leptospira serovars bratislava, canicola, grippotyphosa and icterohaemorrhagiae. onset of immunity: immunity has been demonstrated from 4 weeks after completion of the primary course. duration of immunity: at least one year following the primary vaccination course.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 6 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae and to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 8–9 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagie serovar icterohaemorrhagiae,to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa and to prevent mortality, clinical signs and infection caused by rabies virus.

Philippines - English - FDA (Food And Drug Administration)

msd animal health (phils.), inc. - inactivated erysipelotrix rhusiopathiae , porcine parvovirus (ppv) , leptospira interrogans ser. canicola , leptospira interrogans ser. icterohaemorrhagiae , leptospira interrogans ser. australis , leptospira interrogans ser. grippotyphosa , leptospira interrogans ser. pomona , leptospira interrogans ser. tarassovi vaccine (vet.) - suspension for injection (im) - formulation: each dose contains: erysipelothrix rhusiopathiae (serotype 2 strain) .......... >1 ppd porcine parvovirus (014 strain) .............. >65 u/ml l. interrogans serogroup canicola serovar portland-vere (ca-12-000 strain) ...... >1408 u/ml l. interrogans serogroup icterohaemorrhagiae serovar copenhagi (ic-02-001 strain).............. >105 u/ml l. interrogans serogroup australis serovar bratislava (as-05-073 strain) .........>655 u/ml l. interrogans serogroup grippotyphosa serovar dadas (gr-01-005 strain) ............ >324 u/ml l. interrogans serogroup pomona serovar pomona (po-01-000 strain) ............> 83 u/ml l. interrogans serogroup tarassovi serovar gatuni (s1148/02 strain) ......>138 u/ml eid - embryo infective dose

Philippines - English - FDA (Food And Drug Administration)

hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated porcine parvovirus , erysipelothrix rhusiopathiae , leptospira interrogans serovar icterohaemorrhagiae , leptospira interrogans serovar canicola , leptospira interrogans serovar pomona , leptospira interrogans serovar hardjo , leptospira interrogans serovar grippotyphosa , leptospira interrogans serovar bratislava vaccine (vet.) - suspension for injection (im) - each 2ml (dose) contains porcine parvovirus (nadl-2 strain) >1.15* eryspelothrix rhusiopathiae (r32e11 strain)>3.34** leptospira interrogans serovar icterohaemorrhagiae->108mo leptospira interrogans serovar canicola-->108mo leptospira interrogans serovar pomona-->108mo leptospira interrogans serovar hardjo-->108mo leptospira interrogans serovar grippotyphosa-->108mo leptospira interrogans serovar bratislava-->108mo *rp, relative potency (elisa) **ies. (inhibition elisa 50%) mo - microorganismus

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

kernfarm b.v. - leptospira interrogans serogroup australis (inactivated) ; leptospira interrogans serogroup pomona (inactivated) ; porcine parvovirus (inactivated) ; leptospira kirschneri serovar gryppotyphosa (inactivated) ; leptospira interrogans serovar icterohaemorrhagiae (inactivated) ; leptospira interrogans serogroup sejroe (inactivated) ; leptospira interrogans serogroup canicola (inactivated) - emulsion for injection - porcine parvovirus; leptospira interrogans australis; leptospira interrogans canicola; leptospira interrogans grippotyphosa; leptospira interrogans icterohaemorrhagiae; leptospira interrogans pomona; leptospira interrogans sejroe - inactivated viral and inactivated bacterial vaccines - pig

Philippines - English - FDA (Food And Drug Administration)

hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated porcine parvovirus , erysipelothrix rhusiopathiae , leptospira interrogans serovar icterohaemorrhagiae , leptospira interrogans serovar canicola , leptospira interrogans serovar pomona , leptospira interrogans serovar hardjo , leptospira interrogans serovar grippotyphosa , leptospira interrogans serovar bratislava vaccine (vet.) - suspension for injection (im) - each 2ml (dose) contains: porcine parvovirus (nadl-2 strain) eryspelothrix rhusiopathiae (r32e11 strain) leptospira interrogans serovar icterohaemorrhagiae leptospira interrogans serovar canicola leptospira interrogans serovar pomona leptospira interrogans serovar hardjo leptospira interrogans serovar grippotyphosa leptospira interrogans serovar bratislava *rp, relative potency (elisa) **iesu (inhibition elisa 50%) mo - microorganisms >1.15* >3.34** 208 mo 10 mo 10 mo 30 mo 10 mo 10 mo

Philippines - English - FDA (Food And Drug Administration)

zoetis philippines, inc.; distributor: zoetis philippines, inc. - inactivated porcine parvovirus (ppv) , erysipelothrix rhusiopathiae , leptospira interrogans ser. bratislava , l. interrogans ser. canicola , l. interrogans ser. grippotyphosa , l. interrogans ser. hardjo , l. interrogans ser. icterohaemorrhagiae , l. interrogans ser. pomona vaccine (vet.) - emulsion for injection (im) - formulation: each 2 ml (dose) contains: porcine parvovirus (nadl-7 strain)..........> 640 ha titer/0.05 ml erysipelothrix rhusiopathiae (cn 3342 strain) ............. > 15.7 ru leptospira interrogans ser. bratislava (jez strain) ............. >1200 nu ser. canicola (c-51 strain) ................... > 1200 nu ser. grippotyphosa (mal 1540 strain) ....... >1200 nu ser. hardjo (who strain) ................................. > 2400 nu ser. icterohaemorrhagiae (nadl 11403 strain) ..... 21200 nu ser. pomona (t262 strain) .........> 1200 nu ha-hemagglutination ru-relative unit nu-nephelometric unit